^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

HDP-103

i
Associations
Trials
Company:
Heidelberg Pharma, Huadong Medicine
Drug class:
PSMA-targeted antibody-drug conjugate, RNA polymerase 2 inhibitor
Associations
Trials